Technology Readiness Level 3 & 4
Our Translation platforms support the development of novel antimicrobials & diagnostics. Effective R&D including studies to determine critical function and laboratory validation support industry through TRL 3 and TRL 4, proving the early-stage performance results required to take products forward. Specialist support is available to progress novel therapeutics from hits to leads. Highly innovative technologies including nanotherapeutics, innovative humanised tissue & microfluidic models, including organoid systems & Organ-on-a-Chip is accessible to industry to fast-track drug discovery. New drug development models are also being developed to support the industry effort to combat multi-drug-resistant superbugs.
Infex, based at Alderley Park in Cheshire, has a range of projects in advanced stages of development. Its lead clinical […]
A range of sophisticated technologies including innovative human tissue & microfluidic models, are available to industry to fast-track drug discovery. […]
The multi-drug-resistant pathogens Pseudomonas aeruginosa and Acinetobacter baumannii are key threats to human health at a global scale. New drugs […]
This Interdisciplinary Research Centre, which also houses the Open Innovation Hub for Antimicrobial Surfaces, features sophisticated surface sensitive spectroscopic and […]
A major focus of 2022 has been the creation of a new study to explore reducing the risk to vulnerable […]
Learn more about collaborating with iiCONDiscover more